About CooperVision
Bringing better vision to the world
Dedication. Expertise. Leadership.
CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellence and close working relationships with our eye care professional customers, CooperVision has helped improve the vision of millions and become a trusted global leader in the contact lens industry…
Manufacturing the widest range of soft contact lens prescription options*1
Selling in over 130 countries2
Making billions of contact lenses annually1
Growing faster than the overall soft contact lens market†1
From our ground-breaking introduction of contact lenses proven to slow the progression of myopia in children‡§3; to our Digital Zone Optics® lens design, developed to address the needs of contact lens wearers who lead digital lifestyles^; to our creation of the world’s first full family of 1 Day silicone hydrogel contact lenses%, CooperVision is advancing the range of what contact lenses can do—and bringing real advantages to contact lens wearers.
Other important information:
*Based on Rx option combinations (sphere, cylinder, axis and add) manufactured, across all soft lenses in sphere, toric and multifocal (including made to order), in silicone hydrogel and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic and photochromatic contact lenses not included. Multiple base curve variants not included.
†Combination of 2013-2018 market research based on global revenue sales and internal estimates.
‡ Compared to a single vision 1 Day lens over a 3 year period.
§ MiSight 1 day contact lenses for vision correction and control of progression of myopia. Product not available in all markets.
^ Only applicable to Biofinity Energys soft contact lenses for vision correction.
%Clariti 1 day soft contact lenses for vision correction.
References:
1 CVI data on file, 2019.
2 CVI data on file, 2020.
3 Chamberlain P et al A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci 2019;96:556–567. Sponsored by CooperVision Inc.
This product may not be right for you, refer to your optometrist for advice. Read the instructions for use before purchase (https://coopervision.co.nz/patient-instruction) and follow the instructions for use.